Related Experiment Videos
Characterization of the mutations in three patients with pyruvate dehydrogenase E1 alpha deficiency
L L Hansen1, G K Brown, D M Kirby
1Murdoch Institute for Research into Birth Defects, Royal Children's Hospital, Melbourne, Victoria, Australia.
Insights
Pyruvate dehydrogenase E1 alpha deficiency causes variable symptoms due to brain dependency and X-linked gene location. Characterizing mutations, like those found in three patients, aids understanding of this condition.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- The human pyruvate dehydrogenase complex is crucial for converting pyruvate to acetyl-CoA.
- Mutations in the E1 alpha subunit of this complex lead to pyruvate dehydrogenase E1 alpha deficiency.
- Clinical presentations of this deficiency are highly variable.
Observation:
- The brain's significant reliance on pyruvate dehydrogenase activity is noted.
- The gene for the somatic form of the E1 alpha subunit is located on the X chromosome.
- Three novel mutations in the pyruvate dehydrogenase E1 alpha subunit were analyzed in patients.
Findings:
- A female patient presented with a three-base pair deletion impacting dephosphorylation.
- Two male patients had a two-base pair deletion causing a frameshift and an Arg to His substitution, respectively.
- All identified mutations were situated near the carboxyl terminus of the E1 alpha subunit.
Implications:
- Understanding these mutations provides insight into the variable clinical manifestations of pyruvate dehydrogenase E1 alpha deficiency.
- Further characterization of subunit interactions and pathophysiology is essential.
- This research contributes to a better understanding of X-linked genetic disorders and their impact on neurological function.
Abstract:
The human pyruvate dehydrogenase complex catalyses the oxidative decarboxylation of pyruvate to acetyl-CoA. Defects in several of the seven subunits have been reported, but the majority of mutations affect the E1 component and especially the E1 alpha subunit. However, the clinical presentation of patients with pyruvate dehydrogenase E1 alpha deficiency is extremely variable. Dependency of the brain on pyruvate dehydrogenase activity and localization of the gene for the somatic form of the pyruvate dehydrogenase E1 alpha subunit to the X chromosome provide the basis for a better understanding of the variation in the clinical manifestations. Further understanding of the function and interaction of subunits and the pathophysiology of pyruvate dehydrogenase deficiency necessitates the characterization of mutations in the pyruvate dehydrogenase complex. We report the analysis of three patients with pyruvate dehydrogenase E1 alpha deficiency. One female has a three base pair deletion which affects dephosphorylation of the subunit. Of two males analysed, one has a two base pair deletion causing a shift in the reading frame. The other has a base change, resulting in an Arg to His substitution. All three mutations are located near the carboxyl terminus of the subunit.